Enzo Biochem, Inc. v. Applera Corp., 599 F.3d 1325 (Fed. Cir. 2010) (LINN, Michel & Plager), rehearing and rehearing en banc denied, 605 F.3d 1347 (Fed. Cir. 2010) (PLAGER, dissenting from denial of panel rehearing) EnzoBiochem03242010

MAJOR ISSUES:  definiteness of claim language; biotechnology; nucelic acid labeling and detection; “substantially interfere”; summary judgment on invalidity by anticipation; prior art references; claim interpretation; claim differentiation Read CPLRG™ 0037

Marrin v. Griffin, 599 F.3d 1290 (Fed. Cir. 2010) (DYK & Bryson; NEWMAN, dissenting) MarrinGriffin03222010
      
MAJOR ISSUES: claim preamble as limitation; anticipation; preamble as basis for distinguishing prior art; prosecution history; negative limitation Read CPLRG™ 0035

Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., 598 F.3d 1336 (Fed. Cir. 2010) (En Banc) (LOURIE, Michel, Newman, Mayer, Bryson, Gajarsa, Dyk & Prost; NEWMAN, additional views; GAJARSA, concurring; RADER & Linn, dissenting-in-part & concurring-in-part; LINN & Rader, dissenting-in-part & concurring-in-part)

Ariad03222010

MAJOR ISSUES: Written description of invention (Section 112); requirement separate from enablement; original claims; support for generic claims; invention described by biological function Read CPLRG™ 0016

Delaware Valley Floral Group, Inc. v. Shaw Rose Nets, LLC, 597 F.3d 1374 (Fed. Cir. 2010) (PROST, Bryson & Linn) DelawareValleyFloral03112010

MAJOR ISSUES: on sale bar; inventor testimony on date of first sale of invention Read CPLRG™ 0034

Laboratory Corp. of America Holdings v. Metabolite Laboratories, Inc., 599 F.3d 1277 (Fed. Cir. 2010) (GAJARSA & Moore; DYK, dissenting)LabCorpMetabolite03112010

MAJOR ISSUES: declaratory judgment; federal court jurisdiction; cases arising under patent law; jurisdiction determined at outset of suit; prior suit resolving infringement issue Read CPLRG™ 0033